Journey Medical (DERM) Operating Margin: 2020-2025
Historic Operating Margin for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -8.67%.
- Journey Medical's Operating Margin rose 1111.00% to -8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was -9.25%, marking a year-over-year increase of 2193.00%. This contributed to the annual value of -24.36% for FY2024, which is 2175.00% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Operating Margin is -8.67%, which was up 54.74% from -19.16% recorded in Q2 2025.
- In the past 5 years, Journey Medical's Operating Margin registered a high of 49.93% during Q3 2023, and its lowest value of -90.02% during Q2 2021.
- In the last 3 years, Journey Medical's Operating Margin had a median value of -19.70% in 2024 and averaged -21.85%.
- In the last 5 years, Journey Medical's Operating Margin plummeted by 7,813bps in 2021 and then skyrocketed by 10,883bps in 2023.
- Over the past 5 years, Journey Medical's Operating Margin (Quarterly) stood at -51.70% in 2021, then crashed by 1,090bps to -62.60% in 2022, then spiked by 4,881bps to -13.79% in 2023, then skyrocketed by 3,019bps to 16.40% in 2024, then skyrocketed by 1,111bps to -8.67% in 2025.
- Its Operating Margin stands at -8.67% for Q3 2025, versus -19.16% for Q2 2025 and -25.30% for Q1 2025.